Trial Profile
A prospective, open-label, randomized, two-period, two-way crossover Pharmacokinetic study of subcutaneous and intravenous formulations of temocillin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Temocillin (Primary) ; Temocillin (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 20 May 2020 Results published in the Journal of Antimicrobial Chemotherapy
- 23 May 2017 New trial record
- 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases